B Przewlocka
Overview
Explore the profile of B Przewlocka including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
106
Citations
895
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mika J, Jurga A, Starnowska J, Wasylewski M, Rojewska E, Makuch W, et al.
Neuroscience
. 2015 Mar;
294:38-50.
PMID: 25769941
Neuropathic pain is a severe clinical problem, often appearing as a co-symptom of many diseases or manifesting as a result of damage to the nervous system. Many drugs and agents...
2.
Starowicz K, Makuch W, Osikowicz M, Piscitelli F, Petrosino S, Di Marzo V, et al.
Neuropharmacology
. 2011 Dec;
62(4):1746-55.
PMID: 22178705
The endocannabinoid anandamide (AEA) activates also transient receptor potential vanilloid-1 (TRPV1) channels. However, no data exist on the potential role of spinal TRPV1 activation by AEA in neuropathic pain. We...
3.
Mika J, Rojewska E, Makuch W, Korostynski M, Luvisetto S, Marinelli S, et al.
Neuroscience
. 2010 Nov;
175:358-66.
PMID: 21111791
Botulinum neurotoxin serotype A (BoNT/A) acts by cleaving synaptosome-associated-protein-25 (SNAP-25) in nerve terminals to inhibit neuronal release and shows long-lasting antinociceptive action in neuropathic pain. However, its precise mechanism of...
4.
Marinelli S, Luvisetto S, Cobianchi S, Makuch W, Obara I, Mezzaroma E, et al.
Neuroscience
. 2010 Sep;
171(1):316-28.
PMID: 20826198
A growing interest was recently focused on the use of Botulinum neurotoxin serotype A (BoNT/A) for fighting pain. The aim of this study was to investigate the effects of BoNT/A...
5.
Wrzosek A, Obara I, Wordliczek J, Przewlocka B
J Physiol Pharmacol
. 2010 Jan;
60(4):71-8.
PMID: 20065499
Neuropathic pain constitutes a serious therapeutic problem. In most cases polytherapy is necessary. Tramadol and antidepressants have common mechanisms of action and are frequently used together in clinical practice, thus...
6.
Mika J, Rojewska E, Makuch W, Przewlocka B
Neuroscience
. 2009 Dec;
165(4):1420-8.
PMID: 19961904
A role of neuropeptides in neuropathic pain development has been implicated; however, the neuroimmune interactions that are involved in the underlying mechanisms may be more important than previously thought. To...
7.
Rodriguez Parkitna J, Korostynski M, Kaminska-Chowaniec D, Obara I, Mika J, Przewlocka B, et al.
J Physiol Pharmacol
. 2006 Oct;
57(3):401-14.
PMID: 17033093
Molecular mechanisms underlying the differences between chronic neuropathic and inflammatory pain are still poorly understood. Identifying those differences should provide insight into the molecular mechanism underlying features unique for neuropathic...
8.
Chadzinska M, Starowicz K, Scislowska-Czarnecka A, Bilecki W, Pierzchala-Koziec K, Przewlocki R, et al.
Immunol Lett
. 2005 Jun;
101(2):185-92.
PMID: 15979727
We have shown that supplementation of proinflammatory agent with a high dose of morphine not only abolishes inflammation-related pain symptoms but also inhibits influx of leukocytes to the inflamed peritoneal...
9.
Wordliczek J, Banach M, Labuz D, Przewlocka B
J Neural Transm (Vienna)
. 2005 Mar;
112(10):1321-9.
PMID: 15785865
The aim of the present research was to assess the influence of a tricyclic antidepressant doxepin administered intrathecally (i.t.) on the pain behavior in the formalin test (100 microl of...
10.
Nalepa I, Vetulani J, Borghi V, Kowalska M, Przewlocka B, Pavone F
J Neural Transm (Vienna)
. 2005 Feb;
112(10):1309-19.
PMID: 15719155
Involvement of the alpha1-adrenoceptor subtypes in early and late phases of formalin pain was investigated by quantitative in vitro autoradiography in the spinal cord and brain structures of CD-1 mice....